Shows
The Harry Glorikian ShowT Cell Engagers: The New Cancer Drug?One of the most amazing successes in the battle against cancer over the last two decades has been the introduction of antibody drugs that harness the body’s own immune system to kill tumor cells. Finding those drugs may sound like a biology problem rather than a machine learning or a big-data problem. But actually, these days, it’s both. Harry's guest this week is Leonard Wossnig, who’s the chief technology officer for a UK company called LabGenius. The company uses a combination of synthetic biology, high-throughput assays, and machine learning to hunt for new drugs within a subcla...2024-01-1638 min